Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Jul 22, 2019 2:51pm

78 Views

Post# 29947803

RE:RE:RE:RE:interest in TH

SPCEO1 - (7/22/2019 2:44:20 PM)
RE:RE:RE:interest in TH

I don't expect the share price to remain this low, so I am not too concerned about the $4 lsiting requirement for NASDAQ (unless the whole market goes in the tank, which is a possiblity). Insider buying is always nice and I would never discourage it, but I also don't need it to validate what I am thinking about TH's prospects.

???

But you do need those silly analists to up their price targets, while TH itself has not that great income?????

Bullboard Posts

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire